{"id":243582,"title":"VICH guideline 52: Bioequivalence - Blood Level Bioequivalence Study (step 4) - 2014 Health Canada Consultation Notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T13:51:02.751000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/veterinary-drugs/consultations/vich-guideline-52-bioequivalence-blood-level-bioequivalence-study-step-4-consultation-notice.html?wbdisable=false","snippet":"VICH guideline 52: Bioequivalence - Blood Level Bioequivalence Study (step 4) - 2014 Health Canada Consultation Notice - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du Canada Search Search Canada.ca…","rawSnapshotUrl":"/api/snapshots/raw/243582","browseUrl":"https://replay.healtharchive.ca/job-1/20250419135102/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/veterinary-drugs/consultations/vich-guideline-52-bioequivalence-blood-level-bioequivalence-study-step-4-consultation-notice.html?wbdisable=false#ha_snapshot=243582","mimeType":"text/html","statusCode":200}